FibroGen Inc $ 39.9 0.25 (0.63%)
| Volume: | 1,851,579 | Avg Vol (1m): | 588,136 |
| Market Cap $: | 3.47 Bil | Enterprise Value $: | 2.88 Bil |
| P/E (TTM): | 86.74 | P/B: | 5.82 |
Manual of Stocks™ Web
Financial Strength | 7.8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 11.83 | ||
| Equity-to-Asset | 0.69 | ||
| Debt-to-Equity | 0.09 | ||
| Debt-to-EBITDA | 0.79 | ||
| Interest Coverage | 5.89 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 8.36 | ||
| Beneish M-Score | -1.67 | ||
| WACC vs ROIC | |||
Profitability | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 11.67 | ||
| Net Margin % | 13.9 | ||
| ROE % | 9.44 | ||
| ROA % | 5.65 | ||
| ROC (Joel Greenblatt) % | 43.93 | ||
| 3-Year Revenue Growth Rate | -5.5 | ||
| 3-Year EBITDA Growth Rate | 10.6 | ||
| 3-Year EPS without NRI Growth Rate | 10.2 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 86.74 | ||
| PE Ratio without NRI | 86.74 | ||
| PB Ratio | 5.82 | ||
| PS Ratio | 10.03 | ||
| EV-to-EBIT | 51.22 | ||
| EV-to-EBITDA | 40.93 | ||
| EV-to-Revenue | 8.18 | ||
| Current Ratio | 9.73 | ||
| Quick Ratio | 9.71 | ||
| Days Sales Outstanding | 6.68 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.7 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 5.82 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 11.81 | ||
| Price-to-Median-PS-Value | 0.9 | ||
| Price-to-Graham-Number | 4.74 | ||
| Earnings Yield (Greenblatt) % | 1.95 |